New combined topical therapy for refractory rosacea
The main pathogenetic aspects of rosacea, various classifications of dermatosis and the modern clinical classification are presented. The symptoms of different forms of rosacea are described. Contradictory of modern scientific concepts of different researchers, approaches to etiology, pathogenesis a...
Main Authors: | E. A. Smirnova, O. Yu. Olisova, N. G. Kochergin |
---|---|
Format: | Article |
Language: | English |
Published: |
State Scientific Center of Dermatovenereology and Cosmetology
2018-12-01
|
Series: | Vestnik Dermatologii i Venerologii |
Subjects: | |
Online Access: | https://www.vestnikdv.ru/jour/article/view/420 |
Similar Items
-
Clinical and erythema-directed imaging evaluation of papulo-pustular rosacea with topical ivermectin: a 32 weeks duration study
by: Federica Dall’Oglio, et al.
Published: (2019-10-01) -
Pathogenetic substantiation of combination therapy for rosacea
by: Alexey A. Kubanov, et al.
Published: (2023-12-01) -
Topical Metronidazole Versus Ivermectin for Low-density Demodex Rosacea: A Rater-blinded, Randomized, Split-face Trial
by: Marvin Chia-Han Yeh, et al.
Published: (2022-11-01) -
Papulopustular rosacea treated with ivermectin 1% cream: remission of the Demodex mite infestation over the time and evaluation of clinical relapses
by: Ilaria Trave, et al.
Published: (2022-10-01) -
1% ivermectin in combination therapy regimens for rosacea
by: E. A. Khlystova, et al.
Published: (2020-10-01)